The written procedures and records for retaining samples were inadequate.
Inspection Record
Medicago USA Inc. — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The controls were inadequate for creating, modifying, reviewing, storing, and/or retrieving records.
The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions.
The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.
The recorded information or details were inadequate.
The handling of standard operating procedures for good manufacturing practices was inadequate.
The handling of raw materials, products, or packaging materials in keeping with pre-approved written procedures or instructions was inadequate.
The temperature and/or humidity control was inadequate.
The controls put in place for electronic signatures were inadequate.
The preventative maintenance program was inadequate for the equipment used in significant processing and/or testing operations. The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.
The availability and/or the content of the written agreement between the raw material vendor and the drug fabricator was inadequate.
About this record
Extracted automatically from the document of the Health Canada inspection on 2021-04-06. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
